Skip to main content

Institut Jules Bordet

The Institut Jules Bordet is an integrated, multidisciplinary centre, unique in Belgium and which enjoys an international reputation. The hospital is devoted entirely to patients affected by cancer. For more than 75 years, our teams have been offering patients leading-edge diagnostic and therapeutic strategies in the prevention, screening and active...
Read More

InhaTarget Therapeutics

Inhatarget Therapeutics is a ULB spin-off company dedicated to the early development of innovative treatments by inhalation of severe and/or chronic respiratory diseases, with a first focus on lung cancer. Inhatarget Therapeutics is currently focusing its activities on the development of its lead product (innovative formulation of cisplatin as a...
Read More

iTeos Therapeutics Inc and iTeos Belgium SA

Teos Therapeutics is a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of differentiated immuno-oncology therapeutics for patients. The company is headquartered in Cambridge, MA with a research center in Gosselies, Belgium. iTeos leverages its understanding of the tumor microenvironment and immunosuppressive pathways to design novel...
Read More


iSTAR Medical is a medtech company developing minimally invasive ophthalmic implants for the treatment of patients with glaucoma. MINIjectTM, made of STAR® material, is iSTAR Medical’s revolutionary microinvasive glaucoma surgery (MIGS) device for patients with primary open-angle glaucoma. iSTAR Medical was founded in 2011 and is headquartered in Wavre, Belgium. iSTAR Medical has developed MINIject using...
Read More

Isalys consulting sa

ISALYS Life Sciences, part of ISALYS Group, is fully dedicated to the development, the industrialization and the production of drugs. We provide business and project support, scientific and technical expertise as well as methodological and operational advice. Various areas are addressed, such as: - galenic, - analytical, - quality, - regulatory affairs,...
Read More


As an innovative and dynamic contract research organization (CRO) InnoSer supports the preclinical pipeline from its facilities in Belgium and the Netherlands. Founded in 2012, our in-depth expertise allows us to provide customized and streamlined early drug development options with well-characterized and near-patient research models. Our services are designed with...
Read More

Secure your place for BioWin Day: empowering health, the premier event for professionals and decision-makers in the life sciences industry.

Register here!